Inventor · disambiguated record
Gene Hung
Also filed as: HUNG GENE
33 granted patents·13 pending applications·227 citations·filing 2003–2025
97Inventor score
Files withIONIS PHARMACEUTICALS INC14ALUMIS INC6BIOGEN MA INC6ISIS PHARMACEUTICALS INC4FRONTHERA U S PHARMACEUTICALS LLC3
Top patents by PatentIndex Score
46 records- 0197US9717750B2Compositions and methods for modulation of SMN2 splicing in a subjectBIOGEN MA INC·Filed 2015·Granted Aug 1, 2017·26 cites·42 claims
- 0297US9057066B2Compositions and their uses directed to huntingtinISIS PHARMACEUTICALS INC·Filed 2012·Granted Jun 16, 2015·37 cites·17 claims
- 0397US8980853B2Compositions and methods for modulation of SMN2 splicing in a subjectBENNETT C FRANK·Filed 2010·Granted Mar 17, 2015·48 cites·4 claims
- 0496US11834660B2Compositions for modulating Ataxin 2 expressionIONIS PHARMACEUTICALS INC·Filed 2021·Granted Dec 5, 2023·2 cites·23 claims
- 0596US11053219B2Substituted pyridines as TYK2 inhibitorsFRONTHERA U S PHARMACEUTICALS LLC·Filed 2020·Granted Jul 6, 2021·9 cites·57 claims
- 0696US10006027B2Methods for modulating Ataxin 2 expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Jun 26, 2018·21 cites·30 claims
- 0795US9273315B2Modulation of huntingtin expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Mar 1, 2016·19 cites·14 claims
- 0894US9926559B2Compositions and methods for modulation of SMN2 splicing in a subjectBIOGEN MA INC·Filed 2014·Granted Mar 27, 2018·12 cites·10 claims
- 0993US10837016B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·2 cites·16 claims
- 1092US11964964B2Thyroid hormone receptor agonists and uses thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2019·Granted Apr 23, 2024·8 cites·18 claims
- 1192US11731956B2Substituted 1,2,4-triazoles as intermediates in the synthesis of TYK2 inhibitorsALUMIS INC·Filed 2022·Granted Aug 22, 2023·1 cites·2 claims
- 1292US10533178B2Methods for modulating Ataxin 2 expressionIONIS PHARMACEUTICALS INC·Filed 2018·Granted Jan 14, 2020·6 cites·28 claims
- 1390US11040972B2Autotaxin inhibitors and uses thereofSICHUAN HAISCO PHARMACEUTICAL CO LTD·Filed 2020·Granted Jun 22, 2021·2 cites·21 claims
- 1490US10619158B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted Apr 14, 2020·2 cites·16 claims
- 1589US11959080B2Methods and compositions for inhibiting PMP22 expressionIONIS PHARMACEUTICALS INC·Filed 2021·Granted Apr 16, 2024·1 cites·29 claims
- 1689US11136577B2Methods and compositions for inhibiting PMP22 expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Oct 5, 2021·4 cites·25 claims
- 1789US9683236B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Jun 20, 2017·5 cites·16 claims
- 1889US8669102B2Modulation of prion expressionBENNETT C FRANK·Filed 2009·Granted Mar 11, 2014·5 cites·30 claims
- 1987US12006306B2Substituted pyridazines as TYK2 inhibitorsALUMIS INC·Filed 2021·Granted Jun 11, 2024·1 cites·16 claims
- 2087US11421231B2Modulation of Huntington expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Aug 23, 2022·1 cites·16 claims
- 2187US10738307B2Compositions and their uses directed to huntingtinIONIS PHARMACEUTICALS INC·Filed 2017·Granted Aug 11, 2020·1 cites·15 claims
- 2287US2024238326A1Compositions and methods for modulation of smn2 splicing in a subjectBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 2385US12351572B2Substituted 1,2,4-triazoles as TYK2 inhibitorsALUMIS INC·Filed 2023·Granted Jul 8, 2025·0 cites·7 claims
- 2485US8906873B2Modulation of huntingtin expressionHUNG GENE·Filed 2010·Granted Dec 9, 2014·8 cites·8 claims
- 2584US10202603B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Feb 12, 2019·2 cites·16 claims
- 2683US9523094B2Methods of treating kennedy's diseaseIONIS PHARMACEUTICALS INC·Filed 2013·Granted Dec 20, 2016·3 cites·14 claims
- 2782US12297431B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2022·Granted May 13, 2025·0 cites·14 claims
- 2879US12060343B2Substituted 1,2,4-triazoles as intermediates in the synthesis of TYK2 inhibitorsALUMIS INC·Filed 2022·Granted Aug 13, 2024·0 cites·6 claims
- 2977US12509681B2Antisense oligonucleotides directed to huntingtinIONIS PHARMACEUTICALS INC·Filed 2020·Granted Dec 30, 2025·0 cites·13 claims
- 3076US10711000B2Autotaxin inhibitors and uses thereofFRONTHERA U S PHARMACEUTICALS LLC·Filed 2019·Granted Jul 14, 2020·1 cites·20 claims
- 3175US2020376018A1Compositions and methods for modulation of smn2 splicing in a subjectBIOGEN MA INC·Filed 2019·Application pending·0 cites
- 3274US12358899B2Thyroid hormone receptor agonists and uses thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2024·Granted Jul 15, 2025·0 cites·13 claims
- 3372US2010069472A1Compositions and their uses directed to huntingtinISIS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 3465US2025276977A1Tyk2 inhibitors and uses thereofALUMIS INC·Filed 2025·Application pending·0 cites
- 3562US2019030058A1Compositions and methods for modulation of smn2 splicing in a subjectBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 3661US2016053256A1Compositions and their uses directed to huntingtinISIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3759US2019040384A1Compositions and methods for modulation of smn2 splicing in a subjectBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 3859US2022177486A1Tyk2 inhibitors and uses thereofESKER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3958US2008009015A1Methods for Producing Olfactory GpcrsARENA PHARM INC·Filed 2004·Application pending·0 cites
- 4055US2023357273A1Tyk2 inhibitors and uses thereofALUMIS INC·Filed 2021·Application pending·0 cites
- 4152US2022017566A1Terpinoid derivatives and uses thereofSICHUAN HAISCO PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 4251US2009280487A1Methods for producing olfactory gpcrsHUNG GENE·Filed 2008·Application pending·0 cites
- 4347US7419826B2Human schwannoma cell lineHOUSE EAR INST·Filed 2003·Granted Sep 2, 2008·0 cites·8 claims
- 4444US11034671B2Apoptosis signal-regulating kinase inhibitors and uses thereofSICHUAN HAISCO PHARMACEUTICAL CO LTD·Filed 2018·Granted Jun 15, 2021·0 cites·16 claims
- 4541US10787430B2Hemoglobin modifier compounds and uses thereofFRONTHERA U S PHARMACEUTICALS LLC·Filed 2017·Granted Sep 29, 2020·0 cites·18 claims
- 4638US2011177522A1Methods for Producing Olfactory GPCRsHUNG GENE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gene Hung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →